FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Alert on BD Covid-19 Reagents

An FDA safety alert warns about an increased risk of a false positive result with Becton Dickinsons BD SARS-CoV-2 Reagents for the BD Max System test....

Federal Register

Exceptions to Labeling for Stockpiled Products

Federal Register notice: FDA seeks comments on an information collection extension for Exceptions or Alternatives To Labeling Requirements for Product...

Novartis Settles Sham Speaker Programs for $678 Million

The Justice Department says Novartis will pay $678 million to settle a whistleblower suit alleging that it operated a sham speaker program to funnel m...

Marketing

CDER to Test Multiple Indication TV Ads

The CDER Office of Prescription Drug Promotion proposes to test whether consumers are challenged by TV ads that promote more than one indication for a...

Federal Register

Guide on Device UDI Compliance Dates

Federal Register notice: FDA makes available a guidance on Unique Device Identification Compliance Dates for certain dates.

Human Drugs

FDA Approves Genentechs Phesgo for Breast Cancer

FDA approves Genentechs outpatient breast cancer drug Phesgo.

Federal Register

Draft Guide on Anti-Infective Drug Products

Federal Register notice: FDA makes available a draft guidance entitled Development of Anti-Infective Drug Products for the Pediatric Population.

Human Drugs

FDA Approves New Indication for Mercks Keytruda

FDA approves a new indication for Mercks Keytruda to treat specified forms of colorectal cancer.

Human Drugs

Anti-Infective Pediatric Drug Development Guidance

FDA publishes a draft guidance with general recommendations for sponsors developing anti-infective drug products for pediatric patients.

Biologics

FDA Stresses High Standards for Coronavirus Vaccine

FDA issues an immediately effective guidance for developers of Covid-19 vaccines saying any vaccine should be effective in at least 50% of those vacci...